z-logo
open-access-imgOpen Access
4CPS-038 Initial experience with the use of pcsk9-inhibitors in the real-world clinical practice
Author(s) -
Sandra Koprivnik,
Amparo Martı́nez,
Isaura Rodríguez Penín
Publication year - 2018
Publication title -
section 4: clinical pharmacy services
Language(s) - English
Resource type - Conference proceedings
DOI - 10.1136/ejhpharm-2018-eahpconf.129
Subject(s) - medicine , prior authorization , evolocumab , statin , pcsk9 , pharmacy , medical prescription , alirocumab , medical record , clinical trial , intensive care medicine , emergency medicine , family medicine , pharmacology , cholesterol , lipoprotein , ldl receptor , apolipoprotein a1

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom